Evidence Tables

Publication Details

Evidence Tables

Evidence Table 1: Disulfiram study designs[Evidence Tables]

Evidence Table 2: Disulfiram study outcomes[Evidence Tables]

Evidence Table 3(a): Disulfiram study side effects[Evidence Tables]

Evidence Table 3(b): Disulfuram study withdrawals[Evidence Tables]

Evidence Table 4: Opiate antagonists (naltrexone and nalmefene) study designs[Evidence Tables]

Evidence Table 5: Opiate antagonists (naltrexone and nalmefene) study outcomes[Evidence Tables]

Evidence Table 6(a): Opiate antagonists study side effects[Evidence Tables]

Evidence Table 6(b): Opiate antagonists study withdrawals [Evidence Tables]

Evidence Table 7: Acamprosate study designs[Evidence Tables]

Evidence Table 8: Acamprosate study outcomes[Evidence Tables]

Evidence Table 9(a): Acamprosate study side effects [Evidence Tables]

Evidence Table 9(b): Acamprosate study withdrawals [Evidence Tables]

Evidence Table 10: Serotonergic agents study designs [Evidence Tables]

Evidence Table 11: Serotonergic agents study outcomes[Evidence Tables]

Evidence Table 12: Serotonergic agents in comorbid depressed or anxious populations study designs[Evidence Tables]

Evidence Table 13: Serotonergic agents in comorbid depressed or anxious populations study outcomes[Evidence Tables]

Evidence Table 14(a): Serotonergic drugs study side effects[Evidence Tables]

Evidence Table 14(b): Serotonergic drugs study withdrawls[Evidence Tables]

Evidence Table 15: Lithium study designs[Evidence Tables]

Evidence Table 16: Lithium study outcomes[Evidence Tables]

Evidence Table 17: Lithium study side effects and study withdrawals[Evidence Tables]